463
Views
14
CrossRef citations to date
0
Altmetric
Control

Patient Satisfaction with a Pressurized Metered-Dose Inhaler with an Integrated Dose Counter Containing a Fixed-Dose Mometasone Furoate/Formoterol Combination

, M.D., , M.D.EQ/PH.D., , M.D., , M.D., , M.D., PH.D. & , M.D.
Pages 625-631 | Published online: 04 Jul 2011

References

  • Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2006. Available at: http://www.goldcopd.com/Guidelineitem.asp?l1=2&l2=1&intId=989. Accessed August 1, 2007.
  • National Asthma Education and Prevention Program. Expert panel report 3: Guidelines for the diagnosis and management of asthma. Full Report 2007. Available at: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm. Accessed January 12, 2010.
  • Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention, 2010. National Heart, Lung, and Blood Institute. Available at: http://www.ginasthma.org/. Accessed February 24, 2010.
  • Newhouse MT, Dolovich MB. Control of asthma by aerosols. N Engl J Med 1986; 315:870–874.
  • Dolovich MB, Ahrens RC, Hess DR, Anderson P, Dhand R, Rau JL, Smaldone GC, Guyatt G. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 2005; 127:335–371.
  • Anderson P. Patient preference for and satisfaction with inhaler devices. Eur Respir Rev 2005; 14:109–116.
  • Wasserman RL, Sheth K, Lincourt WR, Locantore NW, Rosenzweig JC, Crim C. Real-world assessment of a metered-dose inhaler with integrated dose counter. Allergy Asthma Proc 2006; 27:486–492.
  • Welch MJ, Nelson HS, Shapiro G, Bensch GW, Sokol WN, Smith JA, Parasuraman BM. Comparison of patient preference and ease of teaching inhaler technique for Pulmicort Turbuhaler versus pressurized metered-dose inhalers. J Aerosol Med 2004; 17:129–139.
  • Williams LK, Pladevall M, Xi H, Peterson EL, Joseph C, Lafata JE, Ownby DR, Johnson CC. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol 2004; 114:1288–1293.
  • Weinstein C, Staudinger H, Scott I, Amar NJ, Laforce C. Dose counter performance of mometasone furoate/formoterol inhalers in subjects with asthma or COPD. Respir Med 2011; 105:979–988.
  • Sheth K, Wasserman RL, Lincourt WR, Locantore NW, Carranza-Rosenzweig J, Crim C. Fluticasone propionate/salmeterol hydrofluoroalkane via metered-dose inhaler with integrated dose counter: performance and patient satisfaction. Int J Clin Pract 2006; 60:1218–1224.
  • Crim C, Lincourt WR, Locantore N, Carranza Rosenzweig JR Handling performance and patient satisfaction of a metered-dose inhaler with integrated dose counter for patients with COPD. Chest Meeting Abstracts, Oct 2005; 128: 258S.
  • Morice A, Stradling J, Barnes N. Assessment of the acceptability of a new salbutamol multidose dry powder inhaler (DPI) in patients with asthma. Clin Drug Investig 2000; 19:195–199.
  • Sander N, Fusco-Walker SJ, Chipps B. MDIS: can you count on them? Ann Allergy Asthma Immunol 2004; 92:147.
  • Sander N, Fusco-Walker SJ, Harder JM, Chipps BE. Dose counting and the use of pressurized metered-dose inhalers: running on empty. Ann Allergy Asthma Immunol 2006; 97:34–38.
  • Shah S, White M, Uryniak T, O’Brien CD. The functionality of a budesonide/formoterol pressurized metered-dose inhaler with an integrated actuation counter. Allergy Asthma Proc 2010; 31:40–48.
  • Moore AC, Stone S. Meeting the needs of patients with COPD: patients’ preference for the Diskus inhaler compared with the Handihaler. Int J Clin Pract 2004; 58:444–450.
  • Rickenbach MA, Julious SA. Assessing fullness of asthma patients’ aerosol inhalers. Br J Gen Pract 1994; 44:317–318.
  • Rubin BK, Durotoye L. How do patients determine that their metered-dose inhaler is empty? Chest 2004; 126:1134–1137.
  • Lenney J, Innes JA, Crompton GK. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI. Respir Med 2000; 94:496–500.
  • Vestbo J, Anderson JA, Calverley PM, Celli B, Ferguson GT, Jenkins C, Knobil K, Willits LR, Yates JC, Jones PW. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax 2009; 64:939–943.
  • Fink JB, Rubin BK. Problems with inhaler use: a call for improved clinician and patient education. Respir Care 2005; 50:1360–1374; discussion 1374–1375.
  • Giraud V, Roche N. Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Respir J 2002; 19:246–251.
  • Lavorini F, Magnan A, Dubus JC, Voshaar T, Corbetta L, Broeders M, Dekhuijzen R, Sanchis J, Viejo JL, Barnes P, Corrigan C, Levy M, Crompton GK. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med 2008; 102:593–604.
  • Prabhakaran L, Lim G, Abisheganaden J, Chee CB, Choo YM. Impact of an asthma education programme on patients’ knowledge, inhaler technique and compliance to treatment. Singapore Med J 2006; 47:225–231.
  • Broeders ME, Molema J, Hop WC, Folgering HT. Inhalation profiles in asthmatics and COPD patients: reproducibility and effect of instruction. J Aerosol Med 2003; 16:131–141.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.